Profile data is unavailable for this security.
About the company
Natac Natural Ingredients SA, formerly IFFE Futura SA, is a Spain-based company dedicated to the research, development and production of natural extracts. The Company operates through two main business segments: Plant Extracts, which focuses on the development and production of natural extracts derived from various plants; and Omega 3, which is dedicated to the production of Omega 3 fatty acids, which are essential nutrients used in dietary supplements and functional foods to support cardiovascular health and other health benefits. The Company has a presence in both national and international markets, offering natural ingredients for the pharmaceutical, nutraceutical, animal feed, pet nutrition, food, and cosmetics industries.
- Revenue in EUR (TTM)32.61m
- Net income in EUR-5.87m
- Incorporated2011
- Employees184.00
- LocationNatac Natural Ingredients SAavenida Rita Levi Montalcini n 14GETAFE 28906SpainESP
- Phone+34 881896049
- Websitehttps://natacgroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deva Holding AS | 335.97m | 6.52m | 290.95m | 3.07k | 45.35 | 0.5671 | 9.27 | 0.866 | 1.66 | 1.66 | 87.44 | 132.42 | 0.5386 | 2.18 | 6.19 | 5,662,927.00 | 1.05 | 9.90 | 1.40 | 14.23 | 34.50 | 40.87 | 1.94 | 17.06 | 1.06 | 0.4296 | 0.1627 | 1.70 | -5.50 | 62.27 | -98.58 | -24.66 | 70.87 | -- |
| Puma Biotechnology Inc | 179.94m | 31.39m | 292.13m | 172.00 | 9.21 | 2.99 | 7.16 | 1.62 | 0.7414 | 0.7414 | 4.23 | 2.29 | 1.00 | 8.06 | 4.81 | 1,232,529.00 | 17.46 | -3.25 | 32.09 | -5.70 | 76.91 | 75.67 | 17.44 | -3.18 | 1.62 | 8.84 | 0.2263 | -- | -2.19 | -3.28 | 40.23 | -- | -28.80 | -- |
| Standard Chem & Pharm Co Ltd | 186.14m | 24.05m | 292.16m | 1.13k | 12.16 | 1.82 | 6.56 | 1.57 | 4.99 | 4.99 | 38.63 | 33.29 | 0.6066 | 2.48 | 5.98 | -- | 10.80 | 10.48 | 19.18 | 19.42 | 42.14 | 43.86 | 17.81 | 18.24 | 1.69 | -- | 0.1034 | 58.43 | 8.81 | 11.51 | 5.46 | 18.52 | 27.42 | 13.30 |
| Shaanxi Kanghui Pharmaceutical Co Ltd | 63.06m | -22.59m | 294.39m | 906.00 | -- | 3.31 | -- | 4.67 | -1.84 | -1.84 | 5.14 | 7.26 | 0.2636 | 1.93 | 2.53 | 566,479.70 | -11.36 | -1.99 | -18.19 | -2.69 | 24.46 | 36.16 | -43.08 | -6.59 | 0.5483 | -2.10 | 0.4726 | -- | -16.54 | 5.42 | -242.62 | -- | -10.54 | -- |
| RPG Life Sciences Ltd | 63.03m | 18.96m | 294.55m | 1.33k | 15.54 | -- | 14.07 | 4.67 | 122.51 | 122.51 | 407.37 | -- | -- | -- | -- | 5,061,758.00 | -- | 21.05 | -- | 27.78 | 64.34 | 63.28 | 30.07 | 16.68 | -- | 174.47 | -- | 24.92 | 12.26 | 11.71 | 109.03 | 44.58 | 27.39 | 37.97 |
| Natac Natural Ingredients SA | 32.61m | -5.87m | 295.68m | 184.00 | -- | 7.67 | 275.58 | 9.07 | -0.0136 | -0.0136 | 0.0755 | 0.0887 | 0.2389 | 0.0504 | 4.21 | 198,840.70 | -4.30 | 1.15 | -6.32 | 1.42 | 97.29 | -- | -18.00 | 6.49 | 0.2161 | -0.2629 | 0.6672 | -- | 35.01 | 91.00 | -93.80 | 3.85 | 563.61 | -- |
| Jiangsu gdk Biotechnology Co Ltd | 14.32m | -15.54m | 298.18m | 452.00 | -- | 2.04 | -- | 20.82 | -1.03 | -1.03 | 0.9461 | 9.67 | 0.0775 | 0.7322 | 1.14 | 257,878.40 | -8.42 | 1.65 | -9.84 | 2.14 | 60.80 | 73.17 | -108.54 | 7.56 | 1.83 | -- | 0.0465 | 53.80 | -39.96 | 3.77 | -31.71 | -- | 12.74 | -- |
| Niox Group PLC | 52.65m | 5.61m | 299.42m | 84.00 | 54.72 | 4.06 | 28.75 | 5.69 | 0.0114 | 0.0122 | 0.1096 | 0.1542 | 0.5804 | 3.28 | 8.85 | 547,619.10 | 6.18 | 0.4655 | 6.66 | 0.5113 | 71.09 | 70.62 | 10.65 | 1.55 | 3.07 | -- | 0.0183 | 788.00 | 13.59 | 3.85 | -64.21 | -- | -37.28 | -- |
| SinoMab Bioscience Ltd | 0.00 | -17.73m | 301.21m | 61.00 | -- | 8.75 | -- | -- | -0.1508 | -0.1508 | 0.00 | 0.2285 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
Data as of Feb 20 2026. Currency figures normalised to Natac Natural Ingredients SA's reporting currency: Euro EUR
0.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Andbank Wealth Management SGIIC SAUas of 11 Feb 2026 | 965.00k | 0.22% |
| Renta 4 Gestora SGIIC SAas of 31 Dec 2025 | 625.92k | 0.14% |
Data from 31 Dec 2025 - 11 Feb 2026Source: FactSet Research Systems Inc.
